Wells Fargo & Company Upgrades Jazz Pharmaceuticals (NASDAQ:JAZZ) to Overweight
Jazz Pharmaceuticals (NASDAQ:JAZZ – Get Free Report) was upgraded by analysts at Wells Fargo & Company from an “equal weight” rating to an “overweight” rating in a research report issued on Thursday, MarketBeat Ratings reports. The brokerage currently has a $170.00 price target on the specialty pharmaceutical company’s stock, up from their previous price target […]
More Stories
Lupin Part 4: Release Date, Cast Members, and Trailer
One of the most popular and engaging mystery thriller series, Lupin, is returning for its fourth part. The series was...
Let’s Talk About Chu Season 2: Release Date, Cast, and More
The romantic-comedy Taiwanese series Let’s Talk About Chu has become one of the most talked-about series since its release in...
Office Romance is Released! Watch Jennifer Lopez and Brett Goldstein’s Exotic Romance
Looking for a romantic-comedy film to watch with your partner or loved ones this weekend? Jennifer Lopez’s recent film, Office...
The Quiet Logistics Shift Changing How Shoppers Collect Fresh Food
Nobody talks about this, but it’s happening everywhere. The way grocery stores handle order collection is changing. Not in a...
Why Offices Sound Worse Than Ever, And the Engineering Fix Hiding in Plain Sight
Open-plan offices were meant to feel modern, bright, and collaborative. In reality, many feel like a mix of café, hallway,...
Ice Age 6: Boiling Point- Release Date, Voice Artist, and Synopsis
Hello, Ice Age fans! Your favourite animated animal movie is returning to the US theaters. Ice Age 6, or Ice...
